TY  - GEN
AU  - Beg,Muhammad Shaalan
AU  - Huang,Xiumei
AU  - Silvers,Molly A
AU  - Gerber,David E
AU  - Bolluyt,Joyce
AU  - Sarode,Venetia
AU  - Fattah,Farjana
AU  - Deberardinis,Ralph J
AU  - Merritt,Matthew E
AU  - Xie,Xian-Jin
AU  - Leff,Richard
AU  - Laheru,Daniel
AU  - Boothman,David A
TI  - Using a novel NQO1 bioactivatable drug, beta-lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancer
SN  - 1096-9098
PY  - 2017///0905
KW  - Albumins
KW  - pharmacology
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Clinical Trials, Phase I as Topic
KW  - Deoxycytidine
KW  - analogs & derivatives
KW  - Humans
KW  - NAD(P)H Dehydrogenase (Quinone)
KW  - antagonists & inhibitors
KW  - Naphthoquinones
KW  - Paclitaxel
KW  - Pancreatic Neoplasms
KW  - drug therapy
KW  - Gemcitabine
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1002/jso.24624
ER  -